诚意药业：第五届董事会第三次会议决议公告

Core Viewpoint - Chengyi Pharmaceutical announced the approval of its 2025 semi-annual report and summary by the third meeting of the fifth board of directors [2] Group 1 - The company held its third meeting of the fifth board of directors on August 26 [2] - The meeting resulted in the approval of the 2025 semi-annual report and summary [2]